GENERAL ATLANTIC, L.P.
New York NY · SEC CIK 0001017645
$21.48亿2026Q1 申报市值
12持仓数
99.8%前十大占比 · 第一大 28.2%
0 / 1新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q1 买入最多 按季末市值估算
ALKT 加仓+$5,243.21万
2026Q1 卖出最多 按季末市值估算
ALHC 清仓-$2.60亿
RVMD 减仓-$2.05亿
CENTESSA PHARMAC 减仓-$1.89亿
XP 减仓-$4,061.23万
NRIX 减仓-$1,232.71万
2026Q1 持仓明细 点表头排序
导出 CSV 🔒| 代码 | 名称 | 市值 ▼ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| DLO | DLOCAL | $6.05亿 | 28.17% | 46,656,695 | 0 | 0.0% | — | 不变 |
| CHYM | CHIME | $3.98亿 | 18.53% | 21,259,683 | 0 | 0.0% | — | 不变 |
| XP | XP, INC | $3.92亿 | 18.23% | 20,566,133 | -2,133,000 | -9.4% | -$4,061.23万 | 减仓 |
| ALKT | ALKAMI | $2.40亿 | 11.19% | 15,337,495 | 3,346,015 | 27.9% | $5,243.21万 | 加仓 |
| PHVS | PHARVARIS | $2.27亿 | 10.56% | 8,031,252 | 0 | 0.0% | — | 不变 |
| — | EUROPEAN WAX CENTER | $7,577.86万 | 3.53% | 13,110,492 | 0 | 0.0% | — | 不变 |
| RVMD | REVOLUTION MEDICINES | $6,883.27万 | 3.20% | 707,791 | -2,105,137 | -74.8% | -$2.05亿 | 减仓 |
| NRIX | NURIX THERAPEUTICS | $6,357.89万 | 2.96% | 4,101,865 | -795,294 | -16.2% | -$1,232.71万 | 减仓 |
| — | CENTESSA PHARMACEUTICALS | $5,381.38万 | 2.50% | 1,354,830 | -4,762,885 | -77.9% | -$1.89亿 | 减仓 |
| RSKD | RISKIFIED | $2,087.40万 | 0.97% | 5,324,998 | 0 | 0.0% | — | 不变 |
| — | GROVE COLLABORATIVE | $316.78万 | 0.15% | 2,474,859 | 0 | 0.0% | — | 不变 |
| BULL | WEBULL | $24.39万 | 0.01% | 50,816 | 0 | 0.0% | — | 不变 |
| ALHC | ALIGNMENT HEALTHCARE | $0 | 0.00% | 0 | -13,167,733 | -100.0% | -$2.60亿 | 清仓 |